| Ausstehende Aktien | 20,555,873 shares |
| Insider-Aktien | 5.054.144 shares |
| Insider-Besitz | 24,59 % |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
N/A
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
N/A
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
CASI Pharmaceuticals, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in CASI / CASI Pharmaceuticals, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in CASI / CASI Pharmaceuticals, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
| Handelsdatum | Insider | Gemeldete Aktien |
Gemeldeter Preis |
Angepasste Aktien |
Angepasster Preis |
Kostenbasis | Tage bis Min |
Preis bei Min |
Max Verlust Vermieden($) |
Max Verlust Vermieden(%) |
|---|---|---|---|---|---|---|---|
| Es sind keine ungeplanten Open-Market-Trades für diesen Insider bekannt |
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-08 | 2022-09-08 | 4 | Huang James | CASI | Common Stock | I | 4,2831 | 33.300 | 143 | 371.517 | ||||
| 2022-09-08 | 2022-09-07 | 4 | Huang James | CASI | Common Stock | I | 3,9965 | 3.111 | 12 | 338.217 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Huang James | CASI | Common Stock | I | 3,8932 | 19.162 | 75 | 335.106 | ||||
| 2022-09-02 | 2022-09-02 | 4 | Huang James | CASI | Common Stock | I | 3,7413 | 400 | 1 | 315.944 | ||||
| 2022-09-02 | 2022-09-01 | 4 | Huang James | CASI | Common Stock | I | 3,7229 | 11.821 | 44 | 315.544 | ||||
| 2022-09-02 | 2022-08-31 | 4 | Huang James | CASI | Common Stock | I | 3,7450 | 24.975 | 94 | 303.723 | ||||
| 2022-08-26 | 2022-08-26 | 4 | Huang James | CASI | Common Stock | I | 3,7488 | 39.527 | 148 | 278.748 | ||||
| 2022-08-26 | 2022-08-24 | 4 | Huang James | CASI | Common Stock | I | 3,7502 | 5.000 | 19 | 239.221 | ||||
| 2022-08-23 | 2022-08-23 | 4 | Huang James | CASI | Common Stock | I | 3,4998 | 40.000 | 140 | 234.221 | ||||
| 2022-08-23 | 2022-08-22 | 4 | Huang James | CASI | Common Stock | I | 3,4641 | 23.105 | 80 | 194.221 | ||||
| 2022-08-23 | 2022-08-19 | 4 | Huang James | CASI | Common Stock | I | 3,2694 | 171.116 | 559 | 171.116 | ||||
| 2022-06-17 | 2022-06-15 | 4 | He Wei-Wu | CASI | Common Stock | D | 3,1800 | 50.000 | 159 | 644.553 | ||||
| 2022-06-17 | 2022-06-14 | 4 | He Wei-Wu | CASI | Common Stock | D | 3,0600 | 2.096 | 6 | 594.553 | ||||
| 2022-06-17 | 2022-06-13 | 4 | He Wei-Wu | CASI | Common Stock | D | 2,9700 | 36.058 | 107 | 592.457 | ||||
| 2022-05-26 | 2022-05-25 | 4 | Zhou Quan | CASI | Stock Option (Right to Buy) | D | 0,47 | 380.645 | 380.645 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Salisbury Franklin Cary jr | CASI | Stock Option (Right to Buy) | D | 0,47 | 388.387 | 388.387 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Huang James | CASI | Stock Option (Right to Buy) | D | 0,47 | 397.419 | 397.419 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Wu Yue Alexander | CASI | Stock Option (Right to Buy) | D | 0,47 | 388.387 | 388.387 | |||||
| 2022-05-26 | 2022-05-25 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Option (Right to Buy) | D | 0,47 | 345.806 | 345.806 | |||||
| 2021-12-06 | 2021-12-02 | 4 | Zukiwski Alexander A | CASI | Employee Stock Option (Right to Buy) | D | 0,87 | -500.000 | 500.000 | |||||
| 2021-11-19 | 2021-11-18 | 4 | He Wei-Wu | CASI | Common Stock | D | 0,9800 | 200.000 | 196 | 5.558.472 | ||||
| 2021-11-19 | 2021-11-17 | 4 | He Wei-Wu | CASI | Common Stock | D | 0,9900 | 200.000 | 198 | 5.362.569 | ||||
| 2021-08-20 | 2021-08-19 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,2600 | 180.000 | 227 | 5.163.994 | ||||
| 2021-08-20 | 2021-08-18 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,2900 | 300.000 | 387 | 4.983.994 | ||||
| 2021-07-26 | 2021-07-24 | 4 | Zhang Larry | CASI | Employee Stock Option (Right to Buy) | D | 1,28 | -800.000 | 800.000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Option (Right to Buy) | D | 1,65 | 98 | 98.349 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Zhou Quan | CASI | Stock Option (Right to Buy) | D | 1,65 | 108.257 | 108.257 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Wu Yue Alexander | CASI | Stock Option (Right to Buy) | D | 1,65 | 110.459 | 110.459 | |||||
| 2021-06-16 | 2021-06-15 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1,73 | 4.000.000 | 4.000.000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Huang James | CASI | Stock Option (Right to Buy) | D | 1,65 | 113.028 | 113.028 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Salisbury Franklin Cary jr | CASI | Stock Option (Right to Buy) | D | 1,65 | 110.459 | 110.459 | |||||
| 2021-03-30 | 2021-03-26 | 4 | He Wei-Wu | CASI | Common Stock | I | 2,0500 | 3.000.000 | 6.150 | 3.000.000 | ||||
| 2020-12-23 | 2020-12-22 | 4 | He Wei-Wu | CASI | Common Stock | D | -380.000 | 4.683.994 | ||||||
| 2020-12-18 | 3 | Xu Weihao Held by spouse | CASI | Common Stock | I | 4.000 | ||||||||
| 2020-12-18 | 2020-12-17 | 4 | Xu Weihao Held by spouse | CASI | Common Stock | I | 2,6300 | 2.279 | 6 | 10.000 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Xu Weihao Held by spouse | CASI | Common Stock | I | 2,6400 | 1.721 | 5 | 7.721 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Xu Weihao | CASI | Employee Stock Option (Right to Buy) | D | 2,61 | 800.000 | 800.000 | |||||
| 2020-12-18 | 2020-12-16 | 4 | Xu Weihao Held by spouse | CASI | Common Stock | I | 2,4400 | 2.000 | 5 | 6.000 | ||||
| 2020-11-24 | 2020-11-23 | 4 | He Wei-Wu | CASI | Common Stock | D | 2,1800 | 100.000 | 218 | 5.063.994 | ||||
| 2020-11-24 | 2020-11-20 | 4 | He Wei-Wu | CASI | Common Stock | D | 2,1200 | 127.471 | 270 | 4.963.994 | ||||
| 2020-07-24 | 2020-07-22 | 4 | Zhang Larry | CASI | Common Stock | D | 1,9000 | 20.153 | 38 | 20.153 | ||||
| 2020-07-24 | 2020-07-22 | 4 | He Wei-Wu | CASI | Common Stock | I | 1,9000 | 1.200.000 | 2.280 | 7.532.347 | ||||
| 2020-07-24 | 2020-07-22 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,9000 | 2.952.426 | 5.610 | 4.836.523 | ||||
| 2020-06-18 | 2020-06-16 | 4 | Huang James | CASI | Stock Option (Right to Buy) | D | 2,63 | 70.400 | 70.400 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Zhou Quan | CASI | Stock Option (Right to Buy) | D | 2,63 | 67.429 | 67.429 | |||||
| 2020-06-18 | 2020-06-16 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Option (Right to Buy) | D | 2,63 | 61.257 | 61.257 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Salisbury Franklin Cary jr | CASI | Stock Option (Right to Buy) | D | 2,63 | 68.800 | 68.800 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Wu Yue Alexander | CASI | Stock Option (Right to Buy) | D | 2,63 | 68.800 | 68.800 | |||||
| 2020-05-21 | 2020-05-20 | 4 | He Wei-Wu | CASI | Common Stock | D | 2,3700 | 56.464 | 134 | 1.884.097 | ||||
| 2020-05-21 | 2020-05-19 | 4 | He Wei-Wu | CASI | Common Stock | D | 2,0300 | 29.801 | 60 | 1.827.663 | ||||
| 2020-05-19 | 2020-05-18 | 4 | He Wei-Wu | CASI | Common Stock | D | 2,0200 | 338.932 | 685 | 1.797.832 | ||||
| 2020-05-19 | 2020-05-15 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,8200 | 100.000 | 182 | 1.458.900 | ||||
| 2020-03-30 | 2020-03-27 | 4 | He Wei-Wu | CASI | Common Stock | D | 2,0800 | 6.880 | 14 | 1.358.900 | ||||
| 2020-03-27 | 2020-03-26 | 4 | He Wei-Wu | CASI | Common Stock | D | 2,0900 | 328.095 | 686 | 1.352.020 | ||||
| 2020-03-27 | 2020-03-25 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,9400 | 196.398 | 381 | 1.023.925 | ||||
| 2020-03-19 | 2020-03-19 | 4 | He Wei-Wu | CASI | Common Stock | I | 1,5700 | 234.488 | 368 | 6.332.347 | ||||
| 2020-03-19 | 2020-03-18 | 4 | He Wei-Wu | CASI | Common Stock | I | 1,5200 | 501.322 | 762 | 6.097.859 | ||||
| 2020-03-19 | 2020-03-17 | 4 | He Wei-Wu | CASI | Common Stock | I | 1,5000 | 264.192 | 396 | 5.596.537 | ||||
| 2020-01-06 | 2019-12-30 | 4 | Wealth Strategy Holding Ltd | CASI | Warrant | D | 1,69 | 0,1250 | -493.827 | -62 | 0 | |||
| 2020-01-06 | 2019-12-30 | 4 | Wealth Strategy Holding Ltd | CASI | Common Stock | D | 1,6900 | 493.827 | 835 | 9.087.888 | ||||
| 2019-12-18 | 2019-12-16 | 4 | He Wei-Wu | CASI | Warrant | I | 1,69 | -374.321 | 0 | |||||
| 2019-12-18 | 2019-12-16 | 4 | He Wei-Wu | CASI | Common Stock | I | 1,6900 | 374.321 | 633 | 5.332.345 | ||||
| 2019-12-17 | 2019-12-15 | 4 | Zukiwski Alexander A | CASI | Employee Stock Option (Right to Buy) | D | 3,16 | -200.000 | 200.000 | |||||
| 2019-09-24 | 2019-09-20 | 4 | Zhang Larry | CASI | Employee Stock Option (Right to Buy) | D | 3,35 | -200.000 | 200.000 | |||||
| 2019-08-20 | 2019-08-16 | 4 | He Wei-Wu | CASI | Common Stock | D | 3,2000 | 20.000 | 64 | 827.527 | ||||
| 2019-08-15 | 2019-08-14 | 4 | He Wei-Wu | CASI | Common Stock | D | 3,1700 | 160.000 | 507 | 807.527 | ||||
| 2019-06-21 | 2019-06-20 | 4 | Zhou Quan | CASI | Stock Option (Right to Buy) | D | 3,13 | 56.731 | 56.731 | |||||
| 2019-06-21 | 2019-06-20 | 4 | He Wei-Wu | CASI | Stock Option (Right to Buy) | D | 2,85 | 4.000.000 | 4.000.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Option (Right to Buy) | D | 3,13 | 51.538 | 51.538 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Ren Ken Keyong | CASI | Stock Option (Right to Buy) | D | 3,13 | 51.538 | 51.538 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Huang James | CASI | Stock Option (Right to Buy) | D | 3,13 | 59.231 | 59.231 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Salisbury Franklin Cary jr | CASI | Stock Option (Right to Buy) | D | 3,13 | 57.885 | 57.885 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Wu Yue Alexander | CASI | Stock Option (Right to Buy) | D | 3,13 | 57.885 | 57.885 | |||||
| 2019-04-04 | 2019-04-02 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 3,3828 | -1.500.000 | -5.074 | 5.397.413 | ||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 15.513.602 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 15.513.602 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 15.513.602 | ||||||||
| 2019-02-06 | 3 | Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. | CASI | Common Stock | I | 11.312.325 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 10.278.975 | ||||||||
| 2019-02-06 | 3 | Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. | CASI | Common Stock | I | 11.312.325 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 10.278.975 | ||||||||
| 2019-02-06 | 3 | Li Dapeng By Zhejiang Kanglaite Group Co., Ltd. | CASI | Common Stock | I | 11.312.325 | ||||||||
| 2019-02-06 | 3 | Li Dapeng | CASI | Common Stock | D | 10.278.975 | ||||||||
| 2019-01-31 | 2019-01-29 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 0,88 | 75.000 | 75.000 | |||||
| 2019-01-31 | 2019-01-29 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 0,88 | 75.000 | 75.000 | |||||
| 2019-01-15 | 2019-01-14 | 4 | Hu Cynthia W. | CASI | Employee Stock Option (Right to Buy) | D | 1,76 | -15.000 | 0 | |||||
| 2019-01-15 | 2019-01-14 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 3,7900 | -3.100 | -12 | 29.685 | ||||
| 2019-01-15 | 2019-01-14 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 1,7600 | 15.000 | 26 | 32.785 | ||||
| 2018-12-21 | 2018-12-19 | 4 | He Wei-Wu | CASI | Common Stock | D | -200.000 | 647.527 | ||||||
| 2018-12-06 | 2018-12-03 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 0,99 | 720.000 | 720.000 | |||||
| 2018-11-14 | 2018-11-13 | 4 | SPARKLE BYTE LTD | CASI | Warrant | D | 1,69 | 0,1250 | -750.771 | -94 | 0 | |||
| 2018-11-14 | 2018-11-13 | 4 | SPARKLE BYTE LTD | CASI | Warrant | D | 1,69 | 0,1250 | -948.982 | -119 | 0 | |||
| 2018-11-14 | 2018-11-13 | 4 | SPARKLE BYTE LTD | CASI | Common Stock | D | 1,6900 | 1.699.753 | 2.873 | 10.198.518 | ||||
| 2018-10-31 | 3 | Wealth Strategy Holding Ltd | CASI | Common Stock | D | 17.188.122 | ||||||||
| 2018-10-31 | 3 | Wealth Strategy Holding Ltd | CASI | Common Stock | D | 17.188.122 | ||||||||
| 2018-10-31 | 3 | Wealth Strategy Holding Ltd | CASI | Common Stock | D | 17.188.122 | ||||||||
| 2018-10-02 | 2018-09-28 | 4 | Chi George | CASI | Stock Options (Right to Buy) | D | 4,67 | 400.000 | 400.000 | |||||
| 2018-07-13 | 2018-07-12 | 4 | CAPITELLI SARA B | CASI | Employee Stock Option (Right to Buy) | D | 1,98 | -35.000 | 0 | |||||
| 2018-07-13 | 2018-07-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 7,4893 | -26.600 | -199 | 0 | ||||
| 2018-07-13 | 2018-07-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 7,4893 | -8.400 | -63 | 26.600 | ||||
| 2018-07-13 | 2018-07-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 1,9850 | 35.000 | 69 | 35.000 | ||||
| 2018-07-03 | 2018-06-29 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options (Right to Buy) | D | 8,23 | 35.000 | 35.000 | |||||
| 2018-07-03 | 2018-06-29 | 4 | Wu Alex | CASI | Stock Options (Right to Buy) | D | 8,23 | 35.000 | 35.000 | |||||
| 2018-07-03 | 2018-06-29 | 4 | Salisbury Franklin Cary jr | CASI | Stock Options (Right to Buy) | D | 8,23 | 35.000 | 35.000 | |||||
| 2018-07-03 | 2018-06-29 | 4 | Zhou Quan | CASI | Stock Options (Right to Buy) | D | 8,23 | 50.000 | 50.000 | |||||
| 2018-07-03 | 2018-06-29 | 4 | Huang James | CASI | Stock Options (Right to Buy) | D | 8,23 | 50.000 | 50.000 | |||||
| 2018-06-12 | 2018-06-11 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 3,22 | 1.000.000 | 1.000.000 | |||||
| 2018-04-13 | 2018-04-12 | 4 | CAPITELLI SARA B | CASI | Employee Stock Option (Right to Buy) | D | 0,88 | -26.978 | 0 | |||||
| 2018-04-13 | 2018-04-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 6,6200 | -18.778 | -124 | 0 | ||||
| 2018-04-13 | 2018-04-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 6,6200 | -8.200 | -54 | 18.778 | ||||
| 2018-04-13 | 2018-04-12 | 4 | CAPITELLI SARA B | CASI | Common Stock | D | 0,8800 | 26.978 | 24 | 26.978 | ||||
| 2018-04-06 | 2018-04-04 | 4 | Huang James | CASI | Common Stock | D | 191 | 191 | ||||||
| 2018-04-06 | 2018-04-04 | 4 | Huang James | CASI | Common Stock | I | -416.666 | 0 | ||||||
| 2018-03-23 | 2018-03-21 | 4 | IDG-Accel China Growth Fund III L.P. | CASI | Warrant | D | 3,69 | 0,1250 | 1.152.839 | 144 | 81.728 | |||
| 2018-03-23 | 2018-03-21 | 4 | IDG-Accel China Growth Fund III L.P. See Explanation of Responses | CASI | Warrant | I | 3,69 | 0,1250 | 1.152.839 | 144 | 81.728 | |||
| 2018-03-23 | 2018-03-21 | 4 | IDG-Accel China Growth Fund III L.P. See Explanation of Responses | CASI | Common Stock | I | 3,1900 | 204.320 | 652 | 646.995 | ||||
| 2018-03-23 | 2018-03-21 | 4 | IDG-Accel China Growth Fund III L.P. | CASI | Common Stock | D | 3,1900 | 2.882.098 | 9.194 | 9.126.375 | ||||
| 2018-03-21 | 2018-03-19 | 4 | He Wei-Wu | CASI | Warrants (Right to Buy) | I | 3,69 | 1.234.567 | 1.234.567 | |||||
| 2018-03-21 | 2018-03-19 | 4 | He Wei-Wu | CASI | Common Stock | I | 3,2400 | 3.086.419 | 10.000 | 4.958.024 | ||||
| 2017-12-22 | 2017-12-22 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0,0100 | 611.740 | 6 | 4.650.262 | ||||
| 2017-12-22 | 2017-12-22 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0,0100 | 907.356 | 9 | 6.897.413 | ||||
| 2017-10-11 | 2017-10-10 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,9500 | 100.000 | 195 | 847.527 | ||||
| 2017-10-10 | 2017-10-06 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,8600 | 100.000 | 186 | 747.527 | ||||
| 2017-10-10 | 2017-10-05 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,8000 | 100.000 | 180 | 647.527 | ||||
| 2017-10-06 | 2017-07-10 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1,01 | 50.000 | 50.000 | |||||
| 2017-10-03 | 2017-09-29 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1,98 | 50.000 | 50.000 | |||||
| 2017-10-03 | 2017-09-29 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 1,98 | 20.000 | 20.000 | |||||
| 2017-09-20 | 2017-09-19 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,7800 | 34.002 | 61 | 547.527 | ||||
| 2017-09-20 | 2017-09-18 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,7500 | 173.500 | 304 | 513.525 | ||||
| 2017-09-18 | 2017-09-15 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,4900 | 127.702 | 190 | 340.025 | ||||
| 2017-09-18 | 2017-09-14 | 4 | He Wei-Wu | CASI | Common Stock | D | 1,2200 | 187.625 | 229 | 212.323 | ||||
| 2017-06-09 | 2017-06-08 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1,01 | 100.000 | 100.000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Zhou Quan | CASI | Stock Options (Right to Buy) | D | 1,01 | 50.000 | 50.000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1,01 | 100.000 | 100.000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Huang James | CASI | Stock Options (Right to Buy) | D | 1,01 | 50.000 | 50.000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Salisbury Franklin Cary jr | CASI | Stock Options (Right to Buy) | D | 1,01 | 35.000 | 35.000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options (Right to Buy) | D | 1,01 | 35.000 | 35.000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | Wu Alex | CASI | Stock Options (Right to Buy) | D | 1,01 | 35.000 | 35.000 | |||||
| 2017-06-09 | 2017-06-08 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 1,01 | 50.000 | 50.000 | |||||
| 2017-04-05 | 2017-04-03 | 4 | Zukiwski Alexander A | CASI | Stock Options (Right to Buy) | D | 1,34 | 300.000 | 300.000 | |||||
| 2016-11-01 | 2016-10-28 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0,0100 | 198.765 | 2 | 4.038.522 | ||||
| 2016-11-01 | 2016-10-28 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0,0100 | 521.692 | 5 | 3.839.757 | ||||
| 2016-11-01 | 2016-10-28 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0,0100 | 294.815 | 3 | 5.990.057 | ||||
| 2016-11-01 | 2016-10-28 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0,0100 | 773.790 | 8 | 5.695.242 | ||||
| 2016-10-25 | 2016-10-24 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1,40 | 202.247 | 202.247 | |||||
| 2016-10-05 | 2016-10-03 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 1,11 | 308.571 | 308.571 | |||||
| 2016-10-05 | 2016-10-03 | 4 | He Wei-Wu See footnotes | CASI | Warrants | I | 1,69 | 0,0250 | 374.321 | 9 | 374.321 | |||
| 2016-10-05 | 2016-10-03 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1,11 | 366.343 | 366.343 | |||||
| 2016-10-05 | 2016-10-03 | 4 | He Wei-Wu See footnotes | CASI | Common Stock | I | 1,1900 | 1.871.605 | 2.227 | 1.871.605 | ||||
| 2016-08-16 | 2016-07-20 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0,0100 | 66.255 | 1 | 3.318.065 | ||||
| 2016-08-16 | 2016-07-20 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0,0100 | 98.271 | 1 | 4.921.452 | ||||
| 2016-08-16 | 2016-07-14 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0,0100 | 394.942 | 4 | 3.251.810 | ||||
| 2016-08-16 | 2016-07-14 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0,0100 | 585.790 | 6 | 4.823.181 | ||||
| 2016-07-06 | 2016-07-05 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1,10 | 84.507 | 84.507 | |||||
| 2016-06-29 | 2016-06-24 | 4 | SPARKLE BYTE LTD | CASI | Warrant | D | 1,69 | 0,0250 | 750.771 | 19 | 1.699.753 | |||
| 2016-06-29 | 2016-06-24 | 4 | SPARKLE BYTE LTD | CASI | Common Stock | D | 1,1900 | 3.753.855 | 4.467 | 8.498.765 | ||||
| 2016-06-27 | 2016-06-24 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1,15 | 369.805 | 369.805 | |||||
| 2016-06-27 | 2016-06-24 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1,15 | 27.027 | 27.027 | |||||
| 2016-06-27 | 2016-06-24 | 4 | Ren Ken Keyong | CASI | Stock Options(Right to Buy) | D | 1,15 | 86.486 | 86.486 | |||||
| 2016-06-03 | 2016-06-02 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 0,86 | 712.112 | 712.112 | |||||
| 2016-06-03 | 2016-06-02 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 0,86 | 87.719 | 87.719 | |||||
| 2016-06-03 | 2016-06-02 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 0,86 | 280.701 | 280.701 | |||||
| 2016-06-03 | 2016-06-02 | 4 | Zhou Quan | CASI | Stock Options (Right to Buy) | D | 1,26 | 50.000 | 50.000 | |||||
| 2016-03-11 | 2016-02-22 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | I | 0,0100 | 680.113 | 7 | 2.856.868 | ||||
| 2016-03-11 | 2016-02-22 | 4 | SPECTRUM PHARMACEUTICALS INC | CASI | Common Stock | D | 0,0100 | 1.008.764 | 10 | 4.237.391 | ||||
| 2016-03-04 | 2016-03-02 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 0,88 | 95.000 | 95.000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Mak Tak W. | CASI | Stock Options (Right to Buy) | D | 0,88 | 35.000 | 35.000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Huang James | CASI | Options (Right to Buy) | D | 0,88 | 75.000 | 75.000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 0,88 | 35.000 | 35.000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Ren Ken Keyong | CASI | Stock Options (Right to Buy) | D | 0,88 | 125.000 | 125.000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Salisbury Franklin Cary jr | CASI | Stock Options (Right to Buy) | D | 0,88 | 35.000 | 35.000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options (Right to Buy) | D | 0,88 | 35.000 | 35.000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 0,88 | 100.000 | 100.000 | |||||
| 2016-03-04 | 2016-03-02 | 4 | Wu Alex | CASI | Options (Right to Buy) | D | 0,88 | 35.000 | 35.000 | |||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4.702.708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8.529.449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4.702.708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8.529.449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4.702.708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4.702.708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4.702.708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8.529.449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4.702.708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8.529.449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8.529.449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8.529.449 | ||||||||
| 2016-01-27 | 3 | Zhou Quan See Explanation of Responses | CASI | Common Stock | I | 4.702.708 | ||||||||
| 2016-01-27 | 3 | Zhou Quan | CASI | Common Stock | D | 8.529.449 | ||||||||
| 2016-01-27 | 2013-03-07 | 4 | IDG-Accel China Growth Fund III L.P. See Explanation of Responses | CASI | Warrant | I | 2,91 | 34.479 | 92.044 | |||||
| 2016-01-27 | 2013-03-07 | 4 | IDG-Accel China Growth Fund III L.P. | CASI | Warrant | D | 2,91 | 486.354 | 1.298.354 | |||||
| 2016-01-27 | 2013-03-07 | 4 | IDG-Accel China Growth Fund III L.P. See Explanation of Responses | CASI | Common Stock | I | 2,4000 | 68.958 | 165 | 360.947 | ||||
| 2016-01-27 | 2013-03-07 | 4 | IDG-Accel China Growth Fund III L.P. | CASI | Common Stock | D | 2,4000 | 972.708 | 2.334 | 5.091.438 | ||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-25 | 3 | Shong Hugo | CASI | Common Stock | D | 9.489.820 | ||||||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken Keyong | CASI | Common Stock | D | 0,7100 | 300 | 0 | 15.000 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken Keyong | CASI | Common Stock | D | 0,7200 | 6.063 | 4 | 14.700 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken Keyong | CASI | Common Stock | D | 0,7400 | 1.100 | 1 | 8.637 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken Keyong | CASI | Common Stock | D | 0,7300 | 7.537 | 6 | 7.537 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken | CASI | Common Stock | D | 0,7100 | 300 | 0 | 15.000 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken | CASI | Common Stock | D | 0,7200 | 6.063 | 4 | 14.700 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken | CASI | Common Stock | D | 0,7400 | 1.100 | 1 | 8.637 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Ren Ken | CASI | Common Stock | D | 0,7300 | 7.537 | 6 | 7.537 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 0,7197 | 11.837 | 9 | 17.785 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 0,7190 | 4.163 | 3 | 5.948 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 0,7497 | 400 | 0 | 1.785 | ||||
| 2016-01-21 | 2016-01-19 | 4 | Hu Cynthia W. | CASI | Common Stock | D | 0,7478 | 400 | 0 | 1.385 | ||||
| 2015-04-08 | 2015-04-06 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1,41 | 175.000 | 175.000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Mak Tak W. | CASI | Stock Options(Right to Buy) | D | 1,41 | 35.000 | 35.000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Huang James | CASI | Options(Right to Buy) | D | 1,41 | 75.000 | 75.000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Wu Alex | CASI | Options(Right to Buy) | D | 1,41 | 35.000 | 35.000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 1,41 | 65.000 | 65.000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1,41 | 100.000 | 100.000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Ren Ken Keyong | CASI | Stock Options(Right to Buy) | D | 1,41 | 225.000 | 225.000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | Salisbury Franklin Cary jr | CASI | Stock Options(Right to Buy) | D | 1,41 | 35.000 | 35.000 | |||||
| 2015-04-08 | 2015-04-06 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options(Right to Buy) | D | 1,41 | 35.000 | 35.000 | |||||
| 2014-11-14 | 2012-08-15 | 4 | CAPITELLI SARA B | CASI | Stock Options (Right to Buy) | D | 1,98 | 20.000 | 20.000 | |||||
| 2014-11-14 | 2014-04-03 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1,84 | 100.000 | 100.000 | |||||
| 2014-11-14 | 2012-08-15 | 4 | Hu Cynthia W. | CASI | Stock Options (Right to Buy) | D | 1,98 | 50.000 | 50.000 | |||||
| 2014-11-14 | 2014-04-03 | 4 | Huang James | CASI | Options(Right to Buy) | D | 1,84 | 100.000 | 100.000 | |||||
| 2014-11-14 | 2014-04-03 | 4 | He Wei-Wu | CASI | Stock Options (Right to Buy) | D | 1,84 | 100.000 | 100.000 | |||||
| 2014-11-14 | 2014-04-03 | 4 | Ren Ken Keyong | CASI | Stock Options(Right to Buy) | D | 1,84 | 100.000 | 100.000 | |||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | I | 7.582.137 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | I | 7.582.137 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | D | 8.634.009 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | I | 7.582.137 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | D | 8.634.009 | ||||||||
| 2014-09-25 | 3 | Spectrum Pharmaceuticals Cayman, L.P. | CASI | Common Stock | D | 8.634.009 | ||||||||
| 2014-09-23 | 2014-09-22 | 4 | SHROTRIYA RAJESH C MD | CASI | Stock Options (Right to Buy) | D | 1,80 | 50.000 | 50.000 | |||||
| 2014-06-03 | 2014-06-02 | 4 | Salisbury Franklin Cary jr | ENMD | Stock Options (Right to Buy) | D | 1,74 | 50.000 | 50.000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Hu Cynthia W. | ENMD | Stock Options (Right to Buy) | D | 1,84 | 130.000 | 130.000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | He Wei-Wu | ENMD | Stock Options (Right to Buy) | D | 1,84 | 100.000 | 100.000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Ren Ken Keyong | ENMD | Stock Options(Right to Buy) | D | 1,84 | 150.000 | 150.000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | CAPITELLI SARA B | ENMD | Stock Options (Right to Buy) | D | 1,84 | 55.000 | 55.000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Wu Alex | ENMD | Options (Right to Buy) | D | 1,84 | 25.000 | 25.000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Mak Tak W. | ENMD | Stock Options (Right to Buy) | D | 1,84 | 25.000 | 25.000 | |||||
| 2014-04-04 | 2014-04-03 | 4 | Huang James | ENMD | Options (Right to Buy) | D | 1,84 | 75.000 | 75.000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | CAPITELLI SARA B | ENMD | Stock Options (Right to Buy) | D | 1,79 | 125.000 | 125.000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | HUNTER CEVERA JENNIE | ENMD | Stock Options (Right to Buy) | D | 1,79 | 37.500 | 37.500 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Hu Cynthia W. | ENMD | Stock Options (Right to Buy) | D | 1,79 | 350.000 | 350.000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | He Wei-Wu | ENMD | Stock Options (Right to Buy) | D | 1,79 | 100.000 | 100.000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | He Wei-Wu | ENMD | Stock Options (Right to Buy) | D | 1,79 | 125.000 | 125.000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Huang James | ENMD | Stock Options (Right to Buy) | D | 1,79 | 50.000 | 50.000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Wu Alex | ENMD | Stock Options (Right to Buy) | D | 1,79 | 50.000 | 50.000 | |||||
| 2013-05-31 | 2013-05-30 | 4 | BUSH DWIGHT L | ENMD | Stock Options (Right to Buy) | D | 1,79 | 37.500 | 37.500 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Mak Tak W. | ENMD | Stock Options (Right to Buy) | D | 1,79 | 37.500 | 37.500 | |||||
| 2013-05-31 | 2013-05-30 | 4 | Ren Ken Keyong | ENMD | Stock Options (Right to Buy) | D | 1,79 | 1.000.000 | 1.000.000 | |||||
| 2013-04-12 | 3 | Huang James See footnotes | ENMD | Common Stock | I | 416.666 | ||||||||
| 2012-08-17 | 2012-08-15 | 4 | Hu Cynthia W. | ENMD | Stock Options (Right to Buy) | D | 1,98 | 75.000 | 75.000 | |||||
| 2012-08-17 | 2012-08-15 | 4 | CAPITELLI SARA B | ENMD | Stock Options (Right to Buy) | D | 1,98 | 35.000 | 35.000 | |||||
| 2012-05-03 | 2012-05-01 | 4 | He Wei-Wu | ENMD | Common Stock | I | 441.072 | 441.072 | ||||||
| 2012-05-03 | 2012-01-20 | 4 | He Wei-Wu | ENMD | Warrants (Right to Buy) | I | 1,40 | 86.957 | 86.957 | |||||
| 2012-05-03 | 2012-05-01 | 4 | Hu Cynthia W. | ENMD | Common Stock | I | 74.982 | 74.982 | ||||||
| 2012-05-03 | 2012-01-20 | 4 | Hu Cynthia W. | ENMD | Warrant (Right to Buy) | I | 1,40 | 14.783 | 14.783 | |||||
| 2012-05-03 | 2012-05-01 | 4 | Mak Tak W. | ENMD | Common Stock | D | 352.857 | 365.376 | ||||||
| 2012-05-03 | 2012-01-20 | 4 | Mak Tak W. | ENMD | Warrants (Right to Buy) | D | 1,40 | 69.565 | 69.565 | |||||
| 2012-04-03 | 2012-04-02 | 4 | Ren Ken Keyong | ENMD | Stock Options (Right to Buy) | D | 2,16 | 150.000 | 150.000 | |||||
| 2012-03-14 | 2012-03-12 | 4 | BUSH DWIGHT L | ENMD | Stock Options (Right to Buy) | D | 2,30 | 100.000 | 100.000 | |||||
| 2012-03-14 | 2012-03-12 | 4 | Mak Tak W. | ENMD | Stock Options (Right to Buy) | D | 2,30 | 125.000 | 125.000 | |||||
| 2012-03-14 | 2012-03-12 | 4 | HUNTER CEVERA JENNIE | ENMD | Stock Options (Right to Buy) | D | 2,30 | 50.000 | 50.000 | |||||
| 2012-03-14 | 2012-03-12 | 4 | RANDALL MARK C M | ENMD | Stock Options (Right to Buy) | D | 2,30 | 50.000 | 50.000 | |||||
| 2012-03-02 | 2012-03-01 | 4 | He Wei-Wu | ENMD | Stock Options (Right to Buy) | D | 1,95 | 250.000 | 250.000 | |||||
| 2012-02-13 | 3 | Mak Tak W. | ENMD | Common Stock | D | 12.519 | ||||||||
| 2012-02-13 | 3 | He Wei-Wu | ENMD | Common Stock | D | 24.698 | ||||||||
| 2012-01-25 | 2012-01-23 | 4 | Hu Cynthia W. | ENMD | Stock Options (Right to Buy) | D | 1,75 | 100.000 | 100.000 | |||||
| 2012-01-25 | 2012-01-23 | 4 | BROOKS DONALD S | ENMD | Stock Options (Right to Buy) | D | 1,75 | 25.000 | 25.000 | |||||
| 2012-01-25 | 2012-01-23 | 4 | TARNOW MICHAEL M | ENMD | Stock Options (Right to Buy) | D | 1,75 | 50.000 | 50.000 | |||||
| 2012-01-25 | 2012-01-23 | 4 | BUSH DWIGHT L | ENMD | Stock Options (Right to Buy) | D | 1,75 | 50.000 | 50.000 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
